Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme

Autores
Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; Fatemi, Setareh; Ramos, Ricardo Luis; Vercesi, Valerio; Ferrari, Cinzia; Cansolino, Laura; Delgrosso, Elena; Liberto, Riccardo Di; Dondi, Daniele; Vadivel, Dhanalakshmi; Chen, Yi-Wei; Chou, Fong-In; Peir, Jinn-Jer; Wu, Chuan-Jen; Tsai, Hui-Yu; Lee, Jia-Cheng; Portu, Agustina Mariana; Dattoli Viegas, Ana Mailen; González, Sara Josefina; Bortolussi, Silva
Año de publicación
2025
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.
Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; Argentina
Fil: Crepaldi, Marco. Universita degli Studi di Pavia; Italia
Fil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Guidi, Claretta. Universita degli Studi di Pavia; Italia
Fil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; Italia
Fil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; Italia
Fil: Chen, Yi-Wei. Taipei Veterans General Hospital; China
Fil: Chou, Fong-In. National Tsing Hua University; China
Fil: Peir, Jinn-Jer. National Tsing Hua University; China
Fil: Wu, Chuan-Jen. National Tsing Hua University; China
Fil: Tsai, Hui-Yu. National Tsing Hua University; China
Fil: Lee, Jia-Cheng. National Tsing Hua University; China
Fil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; Argentina
Fil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Materia
BNCT
Cell survival curves
Dosimetry
Glioblastoma multiforme
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/281487

id CONICETDig_40026e7add7a2e7cff07b9d45265b6a3
oai_identifier_str oai:ri.conicet.gov.ar:11336/281487
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiformeMarcaccio, BarbaraCrepaldi, MarcoPostuma, IanSimeone, EricaGuidi, ClarettaFatemi, SetarehRamos, Ricardo LuisVercesi, ValerioFerrari, CinziaCansolino, LauraDelgrosso, ElenaLiberto, Riccardo DiDondi, DanieleVadivel, DhanalakshmiChen, Yi-WeiChou, Fong-InPeir, Jinn-JerWu, Chuan-JenTsai, Hui-YuLee, Jia-ChengPortu, Agustina MarianaDattoli Viegas, Ana MailenGonzález, Sara JosefinaBortolussi, SilvaBNCTCell survival curvesDosimetryGlioblastoma multiformehttps://purl.org/becyt/ford/1.3https://purl.org/becyt/ford/1Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; ArgentinaFil: Crepaldi, Marco. Universita degli Studi di Pavia; ItaliaFil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Guidi, Claretta. Universita degli Studi di Pavia; ItaliaFil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; ItaliaFil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; ItaliaFil: Chen, Yi-Wei. Taipei Veterans General Hospital; ChinaFil: Chou, Fong-In. National Tsing Hua University; ChinaFil: Peir, Jinn-Jer. National Tsing Hua University; ChinaFil: Wu, Chuan-Jen. National Tsing Hua University; ChinaFil: Tsai, Hui-Yu. National Tsing Hua University; ChinaFil: Lee, Jia-Cheng. National Tsing Hua University; ChinaFil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; ArgentinaFil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; ArgentinaFil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaAmerican Association of Physicists in Medicine2025-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/281487Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-26170094-2405CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.17693info:eu-repo/semantics/altIdentifier/doi/10.1002/mp.17693info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-02-26T10:26:19Zoai:ri.conicet.gov.ar:11336/281487instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-02-26 10:26:20.077CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
title Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
spellingShingle Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
Marcaccio, Barbara
BNCT
Cell survival curves
Dosimetry
Glioblastoma multiforme
title_short Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
title_full Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
title_fullStr Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
title_full_unstemmed Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
title_sort Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme
dc.creator.none.fl_str_mv Marcaccio, Barbara
Crepaldi, Marco
Postuma, Ian
Simeone, Erica
Guidi, Claretta
Fatemi, Setareh
Ramos, Ricardo Luis
Vercesi, Valerio
Ferrari, Cinzia
Cansolino, Laura
Delgrosso, Elena
Liberto, Riccardo Di
Dondi, Daniele
Vadivel, Dhanalakshmi
Chen, Yi-Wei
Chou, Fong-In
Peir, Jinn-Jer
Wu, Chuan-Jen
Tsai, Hui-Yu
Lee, Jia-Cheng
Portu, Agustina Mariana
Dattoli Viegas, Ana Mailen
González, Sara Josefina
Bortolussi, Silva
author Marcaccio, Barbara
author_facet Marcaccio, Barbara
Crepaldi, Marco
Postuma, Ian
Simeone, Erica
Guidi, Claretta
Fatemi, Setareh
Ramos, Ricardo Luis
Vercesi, Valerio
Ferrari, Cinzia
Cansolino, Laura
Delgrosso, Elena
Liberto, Riccardo Di
Dondi, Daniele
Vadivel, Dhanalakshmi
Chen, Yi-Wei
Chou, Fong-In
Peir, Jinn-Jer
Wu, Chuan-Jen
Tsai, Hui-Yu
Lee, Jia-Cheng
Portu, Agustina Mariana
Dattoli Viegas, Ana Mailen
González, Sara Josefina
Bortolussi, Silva
author_role author
author2 Crepaldi, Marco
Postuma, Ian
Simeone, Erica
Guidi, Claretta
Fatemi, Setareh
Ramos, Ricardo Luis
Vercesi, Valerio
Ferrari, Cinzia
Cansolino, Laura
Delgrosso, Elena
Liberto, Riccardo Di
Dondi, Daniele
Vadivel, Dhanalakshmi
Chen, Yi-Wei
Chou, Fong-In
Peir, Jinn-Jer
Wu, Chuan-Jen
Tsai, Hui-Yu
Lee, Jia-Cheng
Portu, Agustina Mariana
Dattoli Viegas, Ana Mailen
González, Sara Josefina
Bortolussi, Silva
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv BNCT
Cell survival curves
Dosimetry
Glioblastoma multiforme
topic BNCT
Cell survival curves
Dosimetry
Glioblastoma multiforme
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.3
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.
Fil: Marcaccio, Barbara. Universita degli Studi di Pavia; Italia. Universidad Nacional de San Martín; Argentina
Fil: Crepaldi, Marco. Universita degli Studi di Pavia; Italia
Fil: Postuma, Ian. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Simeone, Erica. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Guidi, Claretta. Universita degli Studi di Pavia; Italia
Fil: Fatemi, Setareh. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ramos, Ricardo Luis. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vercesi, Valerio. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Ferrari, Cinzia. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Cansolino, Laura. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Delgrosso, Elena. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Liberto, Riccardo Di. San Matteo Polyclinic. Foundation I.R.C.C.S.; Italia
Fil: Dondi, Daniele. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
Fil: Vadivel, Dhanalakshmi. Universita degli Studi di Pavia; Italia
Fil: Chen, Yi-Wei. Taipei Veterans General Hospital; China
Fil: Chou, Fong-In. National Tsing Hua University; China
Fil: Peir, Jinn-Jer. National Tsing Hua University; China
Fil: Wu, Chuan-Jen. National Tsing Hua University; China
Fil: Tsai, Hui-Yu. National Tsing Hua University; China
Fil: Lee, Jia-Cheng. National Tsing Hua University; China
Fil: Portu, Agustina Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Comisión Nacional de Energía Atómica; Argentina. Universidad Nacional de San Martín; Argentina
Fil: Dattoli Viegas, Ana Mailen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: González, Sara Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martín; Argentina. Comisión Nacional de Energía Atómica; Argentina
Fil: Bortolussi, Silva. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universita degli Studi di Pavia; Italia. Istituto Nazionale di Fisica Nucleare; Italia
description Background: Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy based on the intravenous administration of a borated drug to the patient and the subsequent irradiation with a low-energy neutron beam. The borated formulation accumulates in the tumor cells, and when neutrons interact with boron, a nuclear capture reaction occurs, releasing high-linear energy transfer, short-range particles that cause lethal damage to the cancer cells. Due to its selectivity, BNCT has the potential to treat aggressive brain tumors such as glioblastoma multiforme (GBM), minimizing the side effects. GBM is a brain neoplasia that poses significant treatment challenges due to its invasiveness and resistance to conventional treatments.Purpose: This work aims to find a suitable model for calculating the photon isoeffective dose for GBM, producing ad hoc radiobiological data to feed the model.Methods: To describe adequately the dose-effect relation of BNCT for GBM, the following strategy has been applied 1.We studied the impact of choosing two different photon radiation types (x- or gamma- rays) 2.We assumed that the correct description of the photon-equivalent dose is obtained with the photon isoeffective dose model. This model calculates the photon dose that equals the cell survival obtained with BNCT, taking into account synergism and sub-lethal damage (SLD). 3.Survival curves as a function of the dose for the human GBM U87 cell line were constructed using the clonogenic assays for irradiation with photons (reference), neutron beam, and BNCT. 4.Survival curves were fitted with the modified linear quadratic model, using SLD repair times derived for U87. The radiobiological parameters were determined for the photon isoeffective dose model. 5.The model was applied to a clinical case that received BNCT in Taiwan. Treatment planning has been simulated using an accelerator-based designed neutron beam following the real treatment process and parameters. The results were discussed and compared to the current method, which employs relative biological effectiveness (RBE) factors to obtain BNCT dosimetry in photon-equivalent units.Results: The dose-survival curves have been obtained with two different photon radiation sources as the reference with a thermal neutron beam and neutrons in the presence of boron. The fitted parameters have been obtained as the input for the photon isoeffective dose and the traditional RBE model. For the first time, the radiobiological parameters of a photon isoeffective dose model were produced for BNCT of GBM. Photon isoeffective dose value can differ up to 32% using gamma photons and low-energy x-rays. Photon isoeffective dose values are lower (17%) than the RBE model currently employed in clinical trials.Conclusion: The results highlight the impact of the reference radiation chosen for the isoeffective dose calculation and the importance of feeding the model with the appropriate radiobiological parameters.The dosimetry obtained with the new radiobiological data is consistent with the dose delivered in modern stereotactic radiotherapy, enabling tumor control predictions.
publishDate 2025
dc.date.none.fl_str_mv 2025-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/281487
Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-2617
0094-2405
CONICET Digital
CONICET
url http://hdl.handle.net/11336/281487
identifier_str_mv Marcaccio, Barbara; Crepaldi, Marco; Postuma, Ian; Simeone, Erica; Guidi, Claretta; et al.; Towards an adequate description of the dose‐response relationship in BNCT of glioblastoma multiforme; American Association of Physicists in Medicine; Medical Physics; 52; 4; 2-2025; 2606-2617
0094-2405
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.17693
info:eu-repo/semantics/altIdentifier/doi/10.1002/mp.17693
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Association of Physicists in Medicine
publisher.none.fl_str_mv American Association of Physicists in Medicine
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1858305856402096128
score 13.176822